Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick L Fitzgibbons

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Archives of Pathology & Laboratory Medicine|June 25, 2005
Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumorsStephen J Qualman, Jay Bowen, Patrick L Fitzgibbons, et al.
Archives of Pathology & Laboratory Medicine|November 9, 2006
Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray SurveyPatrick L Fitzgibbons, Douglas A Murphy, David M Dorfman, et al.
Archives of Pathology & Laboratory Medicine|July 1, 2014
Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation proceduresKathryn S Dyhdalo, Patrick L Fitzgibbons, Jeffery D Goldsmith, et al.
Archives of Pathology & Laboratory Medicine|May 24, 2019
Localized Renal Masses: Comment on Recent American Urological Association GuidelineLisa A Fatheree, Patrick L Fitzgibbons, Priya Rao, et al.
Archives of Pathology & Laboratory Medicine|May 6, 2010
Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratoriesRaouf E Nakhleh, Erin E Grimm, Michael O Idowu, et al.
Archives of Pathology & Laboratory Medicine|June 8, 2010
Recommendations for validating estrogen and progesterone receptor immunohistochemistry assaysPatrick L Fitzgibbons, Douglas A Murphy, M Elizabeth H Hammond, et al.
Archives of Pathology & Laboratory Medicine|February 20, 2024
The Journey to Improve the College of American Pathologists Cancer Biomarker Reporting ProtocolsBrett Baskovich, Alexander Baras, Raja R Seethala, et al.
Archives of Pathology & Laboratory Medicine|May 4, 2017
The Future of College of American Pathologists Cancer Protocols: Maintaining a Commitment to Patient Safety While Improving the User ExperienceRaouf E Nakhleh, Patrick L Fitzgibbons, Mary Kay Washington, et al.
Archives of Pathology & Laboratory Medicine|November 23, 2017
In ReplyRaouf E Nakhleh, Patrick L Fitzgibbons, Mary Kay Washington, et al.
Archives of Pathology & Laboratory Medicine|January 2, 2013
Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratoriesLindsay B Hardy, Patrick L Fitzgibbons, Jeffery D Goldsmith, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Archives of Pathology & Laboratory Medicine|June 25, 2005
Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumorsStephen J Qualman, Jay Bowen, Patrick L Fitzgibbons, et al.
Archives of Pathology & Laboratory Medicine|November 9, 2006
Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray SurveyPatrick L Fitzgibbons, Douglas A Murphy, David M Dorfman, et al.
Archives of Pathology & Laboratory Medicine|July 1, 2014
Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation proceduresKathryn S Dyhdalo, Patrick L Fitzgibbons, Jeffery D Goldsmith, et al.
Archives of Pathology & Laboratory Medicine|May 24, 2019
Localized Renal Masses: Comment on Recent American Urological Association GuidelineLisa A Fatheree, Patrick L Fitzgibbons, Priya Rao, et al.
Archives of Pathology & Laboratory Medicine|May 6, 2010
Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratoriesRaouf E Nakhleh, Erin E Grimm, Michael O Idowu, et al.
Archives of Pathology & Laboratory Medicine|June 8, 2010
Recommendations for validating estrogen and progesterone receptor immunohistochemistry assaysPatrick L Fitzgibbons, Douglas A Murphy, M Elizabeth H Hammond, et al.
Archives of Pathology & Laboratory Medicine|February 20, 2024
The Journey to Improve the College of American Pathologists Cancer Biomarker Reporting ProtocolsBrett Baskovich, Alexander Baras, Raja R Seethala, et al.
Archives of Pathology & Laboratory Medicine|May 4, 2017
The Future of College of American Pathologists Cancer Protocols: Maintaining a Commitment to Patient Safety While Improving the User ExperienceRaouf E Nakhleh, Patrick L Fitzgibbons, Mary Kay Washington, et al.
Archives of Pathology & Laboratory Medicine|November 23, 2017
In ReplyRaouf E Nakhleh, Patrick L Fitzgibbons, Mary Kay Washington, et al.
Archives of Pathology & Laboratory Medicine|January 2, 2013
Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratoriesLindsay B Hardy, Patrick L Fitzgibbons, Jeffery D Goldsmith, et al.
Pageof 6